Home
Almirall

Almirall Market Share Analysis for June 2026

Almirall is a global pharmaceutical company dedicated to medical dermatology, collaborating with leading scientists, healthcare professionals and patients.

Industry: N/A

Domainalmirall.it

Year Founded1943

Employees1001 - 5000

Annual Revenue> $1B

Almirall

Almirall (including company regionals)

almirall.it

See more website traffic and engagement information

Almirall Revenue up to June 2026 is > 1B

revenue generated by Almirall top domains

Almirall top domains revenue over 3 years

Revenue for Almirall top domains

almirall.it> 1B

See more with Sales Intelligence

Almirall Stock price in June 2026

Almirall stock is traded under the ticker #ALM. Below you can review Almirall stock performance in the past 12 months up to June 2026

Total visits to Almirall's top domains

Understand Almirall market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

almirall.it4.3K

See more with Sales Intelligence

Avg. visit duration in Almirall's top domains

Analyze Almirall engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

almirall.it00:00:21

See more with Sales Intelligence

Avg. pageviews on Almirall's top domains

See how Almirall keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

almirall.it1.64

See more with Sales Intelligence

Almirall top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Almirall

These are the website technologies, by industry, used by Almirall top domains

Advertising (10)

DoubleClick

Widget (5)

reCAPTCHA

Conversion & Analytics (3)

Google Analytics

Social (3)

Instagram

More Technologies

12

See all

News & Signals from Almirall

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlmirall, S.A is developing mRNA-based therapies in medical dermatology.Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology.

NewsAlmirall, S.A is developing novel treatments for dermatological diseases.Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases.

NewsAlmirall, S.A partners with Centre de Regulació Genòmica.Almirall announces partnership with the Centre for Genomic Regulation (CRG) to identify biomarkers for novel atopic dermatitis treatments.